Sage Corporation's post-closing trial balance at December 31, 2017, is


Ask a Question

Sage Corporation's post-closing trial balance at December 31, 2017, is shown as follows. SAGE CORPORATION POST-CLOSING TRIAL BALANCE DECEMBER 31, 2017 Dr. Cr. Accounts payable$ 166,200Accounts receivable$ 503,000Accumulated depreciation—buildings18

Sale price $15.00 Regular price $30.00

Sage Corporation's post-closing trial balance at December 31, 2017, is shown as follows.

SAGE CORPORATION

POST-CLOSING TRIAL BALANCE

DECEMBER 31, 2017

Dr.

Cr.

Accounts payable$ 166,200Accounts receivable$ 503,000Accumulated depreciation—buildings181,000Additional paid-in capital in excess of par—common1,318,000 From treasury stock175,000Allowance for doubtful accounts30,000Bonds payable322,000Buildings1,344,000Cash194,000Common stock ($1 par)180,000Dividends payable (preferred stock—cash)3,800Inventory535,000Land361,000Preferred stock ($50 par)500,000Prepaid expenses37,000Retained earnings279,000Treasury stock (common at cost)181,000 Totals$3,155,000$3,155,000

At December 31, 2017, Sage had the following number of common and preferred shares.

Common

Preferred

Authorized540,00060,000Issued180,00010,000Outstanding174,00010,000

The dividends on preferred stock are $4 cumulative. In addition, the preferred stock has a preference in liquidation of $50 per share.

the stockholders' equity section of Sage's balance sheet at December 31, 2017?

Questions & Answers

Have a Question?

Be the first to ask a question about this.

Ask a Question